Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
Digital content

17 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251117333357/en/Epirium-Bio-Presented-Positive-Phase-1-Safety-Pharmacokinetics-and-Pharmacodynamics-Data-for-MF-300-Supporting-its-Role-in-Muscle-Health-as-a-Late-Breaker-at-the-Gerontological-Society-of-America-Annual-Scientific-Meeting-2025

24 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250924461947/en/Epirium-Bio-Announces-Positive-Phase-1-Clinical-Trial-Results-Evaluating-MF-300-in-Healthy-Volunteers-A-First-In-Class-Oral-15-PGDH-Enzyme-Inhibitor-For-the-Treatment-of-Sarcopenia

21 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250721709030/en/Epirium-Bio-Completes-Dosing-in-First-In-Human-Phase-1-Clinical-Trial-Evaluating-MF-300-A-First-In-Class-Oral-15-PGDH-Enzyme-Inhibitor-For-the-Treatment-of-Sarcopenia

30 Jan 2025
// BUSINESSWIRE

23 Dec 2024
// BUSINESSWIRE

13 Nov 2024
// BUSINESSWIRE
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE